{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:51:56Z","timestamp":1776387116639,"version":"3.51.2"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.clinthera.2014.09.005","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T03:01:50Z","timestamp":1414033310000},"page":"1303-1316","source":"Crossref","is-referenced-by-count":74,"title":["Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia"],"prefix":"10.1016","volume":"36","author":[{"given":"Abhay","family":"Dhand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkh546","article-title":"Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections","volume":"55","author":"Steenbergen","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib2","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.47.8.2538-2544.2003","article-title":"Correlation of daptomycin bactericidal activity and membrane depolarization in staphylococcus aureus","volume":"47","author":"Silverman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1592\/phco.24.1.41.34802","article-title":"Daptomycin","volume":"24","author":"Tedesco","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.005_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","article-title":"In vivo pharmacodynamic activity of daptomycin","volume":"48","author":"Safdar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cbi.2004.08.004","article-title":"An evaluation of the P450 inhibition and induction potential of daptomycin in primary human hepatocytes","volume":"150","author":"Oleson","year":"2004","journal-title":"Chem Biol Interact"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children: Executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.005_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1473-3099(09)70200-2","article-title":"Susceptibility relationship between vancomycin and daptomycin in staphylococcus aureus: Facts and assumptions","volume":"9","author":"Moise","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1128\/AAC.00432-10","article-title":"VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant staphylococcus aureus","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2014.09.005_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in staphylococcus aureus: Role of the cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.005_bib11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic basis for in vivo daptomycin resistance in enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.005_bib12","doi-asserted-by":"crossref","first-page":"e34953","DOI":"10.1371\/journal.pone.0034953","article-title":"Antibiotic resistance is prevalent in an isolated cave microbiome","volume":"7","author":"Bhullar","year":"2012","journal-title":"PLoS One"},{"issue":"2A","key":"10.1016\/j.clinthera.2014.09.005_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(83)90088-8","article-title":"Rationale for use of antimicrobial combinations","volume":"75","author":"Moellering","year":"1983","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib14","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0891-5520(20)30277-4","article-title":"Synergism and antagonism","volume":"3","author":"Eliopoulos","year":"1989","journal-title":"Infect Dis Clin North Am"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2014.09.005_bib15","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1093\/clinids\/8.Supplement_3.S305","article-title":"Interaction between beta-lactam and other antibiotics","volume":"8","author":"Holm","year":"1986","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2165\/00003495-199652030-00005","article-title":"Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician","volume":"52","author":"Rybak","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2014.09.005_bib17","first-page":"179","article-title":"Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against Gram-negative bacilli in murine thigh-infection and pneumonitis models","volume":"74","author":"Leggett","year":"1990","journal-title":"Scand J Infect Dis Suppl"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.005_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/594122","article-title":"Severity of gentamicin\u2019s nephrotoxic effect on patients with infective endocarditis: A prospective observational cohort study of 373 patients","volume":"48","author":"Buchholtz","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible staphylococcus aureus bacteremia: A meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.clinthera.2014.09.005_bib22","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2014.09.005_bib23","doi-asserted-by":"crossref","DOI":"10.3410\/M4-4","article-title":"Reduced vancomycin susceptibility among clinical staphylococcus aureus isolates (\u2018the MIC creep\u2019): Implications for therapy","volume":"4","author":"Dhand","year":"2012","journal-title":"F1000 Med Rep"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.005_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in staphylococcus aureus infections: A systematic review and meta-analysis","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijantimicag.2013.05.005","article-title":"Daptomycin: The role of high-dose and combination therapy for Gram-positive infections","volume":"42","author":"Gould","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant staphylococcus aureus: Role of enhanced daptomycin binding","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.005_bib27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cit560","article-title":"The empirical combination of vancomycin and a beta-lactam for staphylococcal bacteremia","volume":"57","author":"McConeghy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2014.09.005_bib28","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"10","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/AAC.01204-13","article-title":"Beta-lactams enhance vancomycin activity against methicillin-resistant staphylococcus aureus bacteremia compared to vancomycin alone","volume":"58","author":"Dilworth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2011.09.028","article-title":"New insights into methicillin-resistant staphylococcus aureus (MRSA) pathogenesis, treatment and resistance","volume":"39","author":"Gould","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MJT.0b013e31821109ec","article-title":"Alternative agents to vancomycin for the treatment of methicillin-resistant staphylococcus aureus infections","volume":"20","author":"Culos","year":"2013","journal-title":"Am J Ther"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2014.09.005_bib32","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1093\/cid\/cit614","article-title":"Methicillin-resistant staphylococcus aureus therapy: Past, present, and future","volume":"58","author":"Rodvold","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.005_bib33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/infdis\/jis482","article-title":"Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant staphylococcus aureus from daptomycin-naive bacteremic patients","volume":"206","author":"Mishra","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2014.09.005_bib35","doi-asserted-by":"crossref","first-page":"e71151","DOI":"10.1371\/journal.pone.0071151","article-title":"Emergence of daptomycin resistance in daptomycin-naive rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms","volume":"8","author":"Mishra","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/649429","article-title":"Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes","volume":"201","author":"Moise","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2014.09.005_bib37","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1128\/AAC.42.12.3169","article-title":"In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source","volume":"42","author":"Bayer","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2014.09.005_bib38","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","article-title":"Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function","volume":"49","author":"Sakoulas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.005_bib39","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jac\/dkp346","article-title":"Effects of daptomycin in combination with other antimicrobial agents: A review of in vitro and animal model studies","volume":"64","author":"Steenbergen","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2014.09.005_bib40","first-page":"619321","article-title":"Antibiotic combinations with daptomycin for treatment of staphylococcus aureus infections","volume":"2011","author":"Nadrah","year":"2011","journal-title":"Chemother Res Pract"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2014.09.005_bib41","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1086\/513854","article-title":"Penicillin-binding protein-mediated resistance in pneumococci and staphylococci","volume":"179","author":"Chambers","year":"1999","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","article-title":"Nafcillin enhances innate immune-mediated killing of methicillin-resistant staphylococcus aureus","volume":"92","author":"Sakoulas","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1574-6968.2006.00568.x","article-title":"Subinhibitory concentrations of beta-lactam induce haemolytic activity in staphylococcus aureus through the SaeRS two-component system","volume":"268","author":"Kuroda","year":"2007","journal-title":"FEMS Microbiol Lett"},{"issue":"2579","key":"10.1016\/j.clinthera.2014.09.005_bib44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.99.2579.452","article-title":"Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci","volume":"99","author":"Kirby","year":"1944","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.005_bib45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the enterococcus: Beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib46","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1128\/AAC.00487-10","article-title":"Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant staphylococcus aureus with evolving oxacillin susceptibility (the \u201cseesaw effect\u201d)","volume":"54","author":"Yang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib47","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.41.8.1788","article-title":"Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in staphylococcus aureus","volume":"41","author":"Moreira","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.005_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijantimicag.2009.12.022","article-title":"In vitro prevention of the emergence of daptomycin resistance in staphylococcus aureus and enterococci following combination with amoxicillin\/clavulanic acid or ampicillin","volume":"35","author":"Entenza","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.005_bib49","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/AAC.01525-12","article-title":"Beta-lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives","volume":"56","author":"Mehta","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.clinthera.2014.09.005_bib50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.005_bib51","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/AAC.43.11.2813","article-title":"Molecular characterization of rpoB mutations conferring cross-resistance to rifamycins on methicillin-resistant staphylococcus aureus","volume":"43","author":"Wichelhaus","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jac\/dkh104","article-title":"Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci","volume":"53","author":"Rand","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2014.09.005_bib53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/infdis\/128.Supplement_3.S433","article-title":"Mechanism of action of trimethoprim-sulfamethoxazole","volume":"128","author":"Hitchings","year":"1973","journal-title":"I. J Infect Dis"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.005_bib54","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/525536","article-title":"Role of folate antagonists in the treatment of methicillin-resistant staphylococcus aureus infection","volume":"46","author":"Proctor","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2011.03636.x","article-title":"Fosfomycin: An old--new antibiotic","volume":"18","author":"Raz","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.005_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/13543780902967624","article-title":"Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: A review of microbiological, animal and clinical studies","volume":"18","author":"Falagas","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.005_bib57","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/522656","article-title":"Failure of daptomycin monotherapy for endocarditis caused by an enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster","volume":"45","author":"Arias","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.clinthera.2014.09.005_bib58","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1128\/AAC.05551-11","article-title":"Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant enterococcus faecium","volume":"56","author":"Sakoulas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.005_bib59","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1128\/AAC.00797-12","article-title":"Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible staphylococcus aureus during therapy improves antibacterial activity","volume":"56","author":"Rose","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.005_bib60","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1128\/AAC.01760-12","article-title":"Combination therapy with ampicillin and daptomycin for treatment of enterococcus faecalis endocarditis","volume":"56","author":"Sierra-Hoffman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib61","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1128\/AAC.02192-12","article-title":"Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with staphylococcus aureus bacteremia and mild to moderate renal impairment","volume":"57","author":"Moise","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib62","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/AAC.02481-12","article-title":"Treatment of high-level gentamicin-resistant enterococcus faecalis endocarditis with daptomycin plus ceftaroline","volume":"57","author":"Sakoulas","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib63","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/444459","article-title":"Endocarditis due to vancomycin-resistant enterococci: Case report and review of the literature","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.005_bib64","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1345\/aph.1M665","article-title":"Successful treatment of daptomycin-nonsusceptible methicillin-resistant staphylococcus aureus bacteremia with the addition of rifampin to daptomycin","volume":"44","author":"Ahmad","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.clinthera.2014.09.005_bib65","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/590257","article-title":"Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin","volume":"47","author":"Lee","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.005_bib66","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00264-013-1856-y","article-title":"The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections","volume":"37","author":"Jugun","year":"2013","journal-title":"Int Orthop"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.005_bib67","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/AAC.00325-12","article-title":"Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant staphylococcus aureus infections","volume":"57","author":"Rose","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.clinthera.2014.09.005_bib68","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1128\/AAC.01046-12","article-title":"Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole","volume":"56","author":"Avery","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib69","first-page":"45","article-title":"High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: A case report and literature review","volume":"21","author":"Di Carlo","year":"2013","journal-title":"Infez Med"},{"issue":"8","key":"10.1016\/j.clinthera.2014.09.005_bib70","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/AAC.06449-11","article-title":"High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant staphylococcus aureus endocarditis","volume":"56","author":"Miro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2014.09.005_bib71","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-11-152","article-title":"High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible staphylococcus aureus: Case report","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.005_bib72","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jecm.2012.09.007","article-title":"Combination therapy of daptomycin and fosfomycin for vancomycin tolerant methicillin-resistant staphylococcus aureus endocarditis complicating metastatic osteomyelitis","volume":"4","author":"Teng","year":"2012","journal-title":"J Exp Clin Med"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.005_bib73","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jhm.236","article-title":"Linezolid- and vancomycin-resistant enterococcus faecium endocarditis: Successful treatment with tigecycline and daptomycin","volume":"2","author":"Jenkins","year":"2007","journal-title":"J Hosp Med"},{"issue":"12","key":"10.1016\/j.clinthera.2014.09.005_bib74","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1345\/aph.1M324","article-title":"Multidrug-resistant enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin","volume":"43","author":"Schutt","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib75","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diagmicrobio.2011.07.001","article-title":"Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia","volume":"71","author":"Kelesidis","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3-5","key":"10.1016\/j.clinthera.2014.09.005_bib76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drup.2013.10.002","article-title":"Reduced glycopeptide and lipopeptide susceptibility in staphylococcus aureus and the \u201cseesaw effect\u201d: Taking advantage of the back door left open?","volume":"16","author":"Ortwine","year":"2013","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.clinthera.2014.09.005_bib77","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1128\/AAC.02274-13","article-title":"Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant enterococcus faecium","volume":"58","author":"Sakoulas","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.005_bib78","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","article-title":"Altering the proclivity towards daptomycin resistance in methicillin-resistant staphylococcus aureus using combinations with other antibiotics","volume":"56","author":"Berti","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.clinthera.2014.09.005_bib79","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1128\/AAC.00019-10","article-title":"Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from staphylococcus aureus and streptococcus pneumoniae","volume":"54","author":"Kosowska-Shick","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AAC.01586-12","article-title":"Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus in a pharmacokinetic\/pharmacodynamic model","volume":"57","author":"Werth","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.clinthera.2014.09.005_bib81","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/AAC.00594-13","article-title":"Beta-lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant staphylococcus aureus","volume":"57","author":"Berti","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"10.1016\/j.clinthera.2014.09.005_bib82","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J Bacteriol"},{"key":"10.1016\/j.clinthera.2014.09.005_bib83","doi-asserted-by":"crossref","unstructured":"Kullar R, McKinnell JA, Sakoulas G. Avoiding the perfect storm: The biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant staphylococcus aureus bacteremia before switching therapy. Clin Infect Dis. 2014. http:\/\/dx.doi.org\/ciu583 [pii].","DOI":"10.1093\/cid\/ciu583"},{"issue":"7","key":"10.1016\/j.clinthera.2014.09.005_bib84","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.amjmed.2010.01.015","article-title":"The value of infectious diseases consultation in staphylococcus aureus bacteremia","volume":"123","author":"Honda","year":"2010","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.clinthera.2014.09.005_bib85","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/cit610","article-title":"Infectious diseases specialty intervention is associated with decreased mortality and lower healthcare costs","volume":"58","author":"Schmitt","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814005979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291814005979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T14:12:05Z","timestamp":1650463925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291814005979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0149291814005979"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2014.09.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}